deltatrials
Completed OBSERVATIONAL NCT05075421

Prognostic Values of Inflammation-based Indices in Gastric Cancer

Comparison of the Prognostic Values of Preoperative Inflammation-based Indices in Patients Undergoing Resection of Gastric Cancer

Sponsor: Gulhane Training and Research Hospital

Conditions Gastric Cancer
Interventions Gastrectomy
Updated 5 times since 2021 Last updated: Mar 16, 2022 Started: Jan 1, 2012 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gastric Cancer and is currently completed. Gulhane Training and Research Hospital leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Nov 2021 – ~Apr 2022 · 5 months · monthly snapshotRecruiting~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Apr 2022 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  5. Nov 2021 — Apr 2022 [monthly]

    Recruiting

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gulhane Training and Research Hospital
Data source: Gulhane Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations